We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Improved Insights into Brain Disorders with New CT Method

By MedImaging International staff writers
Posted on 07 Jun 2011
European researchers have developed a new method for making detailed X-ray images of brain cells. The method, called small-angle X-ray-scattering computed tomography (SAXS-CT), can map the myelin sheaths of nerve cells, which are important indicators for disorders such as multiple sclerosis and Alzheimer's disease (AD).

The study's findings have been published in May 2011 in the journal NeuroImage. The myelin sheaths of nerve cells are lamellar membranes surrounding the neuronal axons. Myelin layers are important to the central nervous system as they ensure the rapid and uninterrupted communication of signals along the neuronal axons. Alterations in the myelin layers are linked with a number of neurodegenerative disorders such as cerebral malaria, multiple sclerosis, and AD.

The development of these diseases are still not fully understood, but are thought to be related to the damage of the myelin layers, so that messages from the brain reach the various areas of the body poorly or not at all. It is similar to an electric cord where the insulating components have been damaged and the current short circuits. To find ways to prevent or treat the diseases it is important to understand the connection between the diseases and the changes in the myelin.

"We have combined two well-known medical examination methods: SAXS and CT scanning. Combined with a specially developed program for data processing, we have been able to examine the variations of the myelin sheaths in a rat brain all the way down to the molecular level without surgery," explained Torben Haugaard Jensen, PhD, from the Niels Bohr Institute at the University of Copenhagen (Denmark). The method is known as molecular X-ray CT, because CT is used to examine myelin at the molecular level.

The research has been carried out in collaboration with researchers in Switzerland, France, and Germany. The experiments took place at the Paul Scherrer Institute (Villigen PSI, Switzerland), where they have a powerful X-ray source that can measure SAXS at a high resolution. Typically, such experiments would give two-dimensional X-ray images that are sharp and precise, but without information on depth. But by integrating the method from CT scanning, where you image from different angles, the researchers have managed to capture three-dimensional (3D) X-ray images.

This has not only required the development of new X-ray methods and research, but has also required the development of new methods for processing data. The extremely detailed measurements of cross sections from different angles meant that there were 800,000 images to be analyzed. Therefore, the researchers have also developed an image-processing program for the SAXS-CT technique. The result is that they can see all of the detailed information from SAXS in spatially resolved.

"We can see the myelin sheaths of the neuronal axons and we can distinguish the layers which have a thickness of 17.6 nm," explained Dr. Torben Haugaard Jensen. "Up until now, you had to cut out a little sample in order to examine the layers in one area and get a single measuring point. With the new method, we can examine 250,000 points at once without cutting into the sample. We can get a complete overview over the concentration and thickness of the myelin and this gives of the ability to determine whether the destruction of the myelin is occurring in spots or across the entire sample," he explained.

The research provides new opportunities for collaboration with investigators at Copenhagen University Hospital and the Panum Institute, with whom they already have close contact. The method cannot be used to diagnose living persons. However, the researchers can obtain a new understanding about the diseases, what kind of damage is taking place and where. They will be able to follow the development of the diseases and find out how the brain is being attacked. This knowledge could possibly be used to develop a treatment, according to the researchers.

Related Links:

Niels Bohr Institute at the University of Copenhagen
Paul Scherrer Institute






Digital Radiographic System
OMNERA 300M
Adjustable Mobile Barrier
M-458
Ultrasound Needle Guidance System
SonoSite L25
Mammo DR Retrofit Solution
DR Retrofit Mammography

Channels

Nuclear Medicine

view channel
Image: LHSCRI scientist Dr. Glenn Bauman stands in front of the PET scanner (Photo courtesy of LHSCRI)

New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer

Detecting recurrent prostate cancer remains one of the most difficult challenges in oncology, as standard imaging methods such as bone scans and CT scans often fail to accurately locate small or early-stage tumors.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.